CuriRx, Inc

CuriRx, Inc is a certified minority woman owned company with 13,000 sqft, well equipped facility, established in 2012 and located in the Wilmington, MA. With combined experience of over 150 years, we offer high quality development services, in following areas • Analytical Development and testing services o Development, Qualification and Validation o Non-GMP and GMP testing and Stability studies o Product characterization o Particle Characterization • Drug Product Development services o Pre-Formulation and Formulation Development, Lyophilization Cycle Development o Parenteral (IM, IV, SC, IT), Ocular Nanotechnology We have successfully developed over 100 clinical formulations involving biological compounds. Our experience includes developing clinical formulations in both liquid and lyophilized dosage forms. The scientists at CuriRx have proven track record with successes in developing commercial products like Humira & Synagis (high con mAbs), Blincyto (Bispecific) and Gattex (Peptide) etc. • Bulk Drug Substance Development, CHOZN, CHOK1, HEK293, ExpiCHO, E,coli o Cell Line and Clone development o Transient transfection, creating stable pools. o Cell Culture 1Lbioreactors-50 Liter’s bioreactors & Purification o Process characterization We are actively hiring! For more details and to explore other open positions, please visit our career page on the website at https://curirx.com/careers/.